858
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Does the time to diagnosis and treatment influence outcome in adults with pleural infections

, , , , , & show all
Article: 2174645 | Received 24 Feb 2022, Accepted 26 Jan 2023, Published online: 01 Feb 2023

References

  • Andrews NC, Parker EF, Shaw RP, et al. Management of non-tuberculous empyema: a statement of the subcommittee on surgery: from American thoracic society. Am Rev Respir Dis.1962;85:935–10. Am Rev Respir Dis 1962;85:935-6.
  • Davies HE, Davies RJO, Davies CWH. Management of pleural infection in adults: British Thoracic society pleural disease guideline 2010. Thorax. 2010;65(Suppl 2):ii41–53.
  • Semenkovich TR, Olsen MA, Puri V, et al. Current state of empyema management. Ann Thorac Surg. 2018;105(6):1589–1596. DOI:10.1016/j.athoracsur.2018.02.027
  • Corcoran JP, Psallidas I, Gerry S, et al. Prospective validation of the RAPID clinical risk prediction score in adult patients with pleural infection: the PILOT study. Eur Respir J. 2020;56(5):2000130. DOI:10.1183/13993003.00130-2020
  • Shen KR, Bribriesco A, Crabtree T, et al. The American association for thoracic surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017;153(6):e129–146. DOI:10.1016/j.jtcvs.2017.01.030
  • Farjah F, Symons RG, Krishnadasan B, et al. Management of pleural space infections: a population-based analysis. J Thorac Cardiovasc Surg. 2007;133(2):346–351. DOI:10.1016/j.jtcvs.2006.09.038
  • Finley C, Clifton J, FitzGerald JM, et al. Empyema: an increasing concern in Canada. Can Respir J. 2008;15(2):85–89. DOI:10.1155/2008/975312
  • Mummadi SR, Stoller JK, Lopez R, et al. Epidemiology of adult pleural disease in the United States . Chest. 2021;160(4):1534-1551. DOI:10.1016/j.chest.2021.05.026
  • Scarci M, Abah U, Solli P, et al. EACTS expert consensus statement for surgical management of pleural empyema. Eur J Cardiothorac Surg. 2015;48(5):642–653. DOI:10.1093/ejcts/ezv272
  • Schultz HEA, Parapneumonisk effusion og pleura empyem. 2018, Dansk Lungemedicinsk Selskab <https://www.lungemedicin.dk/fagligt/44-empyema-pleurae.html>.
  • Study Quality Assessment Tools, N., Study Quality Assessment Tools, NHLBI: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools.
  • Nayak R, Brogly SB, Lajkosz K, et al. Outcomes of operative and nonoperative treatment of thoracic empyema: a population-based study. Ann Thorac Surg. 2019;108(5):1456–1463. DOI:10.1016/j.athoracsur.2019.05.090
  • Bongiolatti S, Voltolini L, Borgianni S, et al. Uniportal thoracoscopic decortication for pleural empyema and the role of ultrasonographic preoperative staging†. Interact Cardiovasc Thorac Surg. 2017;24(4):560–566. DOI:10.1093/icvts/ivw423
  • Jagelavicius Z, Jovaisas V, Mataciunas M, et al. Preoperative predictors of conversion in thoracoscopic surgery for pleural empyema†. Eur J Cardiothorac Surg. 2017;52(1):70–75. DOI:10.1093/ejcts/ezx054
  • Metin M, Yeginsu A, Sayar A, et al. Treatment of multiloculated empyema thoracis using minimally invasive methods. Singapore Med J. 2010;51(3):242–246.
  • Stefani A, Aramini B, della Casa G, et al. Preoperative predictors of successful surgical treatment in the management of parapneumonic empyema. Ann Thorac Surg. 2013;96(5):1812–1819. DOI:10.1016/j.athoracsur.2013.06.013
  • Wozniak CJ, Paull DE, Moezzi JE, et al. Choice of first intervention is related to outcomes in the management of empyema. Ann Thorac Surg. 2009;87(5):1525–1530. discussion 1530-1. DOI:
  • Chung JH, Lee SH, Kim KT, et al. Optimal timing of thoracoscopic drainage and decortication for empyema. Ann Thorac Surg. 2014;97(1):224–229. DOI:10.1016/j.athoracsur.2013.08.039
  • Lardinois D, Gock M, Pezzetta E, et al. Delayed referral and gram-negative organisms increase the conversion thoracotomy rate in patients undergoing video-assisted thoracoscopic surgery for empyema. Ann Thorac Surg. 2005;79(6):1851–1856. DOI:10.1016/j.athoracsur.2004.12.031
  • Luque Paz D, Bayeh B, Chauvin P, et al. Intrapleural use of urokinase and DNase in pleural infections managed with repeated thoracentesis: a comparative cohort study. PLoS ONE. 2021;16(9):e0257339. DOI:10.1371/journal.pone.0257339
  • Maskell NA, Davies CWH, Nunn AJ, et al. U.K. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med. 2005;352(9):865–874. DOI:10.1056/NEJMoa042473
  • Rahman NM, Maskell NA, West A, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011;365(6):518–526. DOI:10.1056/NEJMoa1012740
  • Light RW. Pleural effusions. Med Clin North Am. 2011;95(6):1055–1070.
  • White HD, Henry C, Stock EM, et al. Predicting long-term outcomes in pleural infections. RAPID score for risk stratification. Ann Am Thorac Soc. 2015;12(9):1310–1316. DOI:10.1513/AnnalsATS.201505-272OC
  • Brims F, Popowicz N, Rosenstengel A, et al. Bacteriology and clinical outcomes of patients with culture-positive pleural infection in Western Australia: a 6-year analysis. Respirology. 2019;24(2):171–178. DOI:10.1111/resp.13395